These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 33230872)

  • 21. [The quantification of human immunodeficiency virus viremia in patients with rapid and slow progression of the disease].
    Bravo R; Soriano V; Martín R; del Romero J; Dronda F; Gutiérrez M; Martínez P; Valencia E; Moreno V; Laguna F
    Med Clin (Barc); 1995 Apr; 104(14):530-4. PubMed ID: 7776732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.
    Zhou J; Neff CP; Liu X; Zhang J; Li H; Smith DD; Swiderski P; Aboellail T; Huang Y; Du Q; Liang Z; Peng L; Akkina R; Rossi JJ
    Mol Ther; 2011 Dec; 19(12):2228-38. PubMed ID: 21952167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals.
    Toyoda M; Kamori D; Tan TS; Goebuchi K; Ohashi J; Carlson J; Kawana-Tachikawa A; Gatanaga H; Oka S; Pizzato M; Ueno T
    Sci Rep; 2020 Nov; 10(1):19416. PubMed ID: 33173092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.
    Choi J; Walker J; Boichuk S; Kirkiles-Smith N; Torpey N; Pober JS; Alexander L
    J Virol; 2005 Jan; 79(1):264-76. PubMed ID: 15596822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
    Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
    J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.
    Terahara K; Ishige M; Ikeno S; Okada S; Kobayashi-Ishihara M; Ato M; Tsunetsugu-Yokota Y
    Microbes Infect; 2015 May; 17(5):378-86. PubMed ID: 25839960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
    Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
    J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.
    Bailey JR; Sedaghat AR; Kieffer T; Brennan T; Lee PK; Wind-Rotolo M; Haggerty CM; Kamireddi AR; Liu Y; Lee J; Persaud D; Gallant JE; Cofrancesco J; Quinn TC; Wilke CO; Ray SC; Siliciano JD; Nettles RE; Siliciano RF
    J Virol; 2006 Jul; 80(13):6441-57. PubMed ID: 16775332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
    Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
    JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of HIV pathogenesis: role of superantigens in disease.
    Torres BA; Tanabe T; Subramaniam PS; Yamamoto JK; Johnson HM
    Alcohol Clin Exp Res; 1998 Aug; 22(5 Suppl):188S-192S. PubMed ID: 9727632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
    Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
    J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma.
    Malaspina A; Moir S; Nickle DC; Donoghue ET; Ogwaro KM; Ehler LA; Liu S; Mican JA; Dybul M; Chun TW; Mullins JI; Fauci AS
    J Virol; 2002 Sep; 76(17):8855-63. PubMed ID: 12163605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
    Günthard HF; Havlir DV; Fiscus S; Zhang ZQ; Eron J; Mellors J; Gulick R; Frost SD; Brown AJ; Schleif W; Valentine F; Jonas L; Meibohm A; Ignacio CC; Isaacs R; Gamagami R; Emini E; Haase A; Richman DD; Wong JK
    J Infect Dis; 2001 May; 183(9):1318-27. PubMed ID: 11294662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-molecule techniques to quantify and genetically characterise persistent HIV.
    Wang XQ; Palmer S
    Retrovirology; 2018 Jan; 15(1):3. PubMed ID: 29316955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env.
    Lenardo MJ; Angleman SB; Bounkeua V; Dimas J; Duvall MG; Graubard MB; Hornung F; Selkirk MC; Speirs CK; Trageser C; Orenstein JO; Bolton DL
    J Virol; 2002 May; 76(10):5082-93. PubMed ID: 11967324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.
    Cohen OJ; Pantaleo G; Holodniy M; Schnittman S; Niu M; Graziosi C; Pavlakis GN; Lalezari J; Bartlett JA; Steigbigel RT
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6017-21. PubMed ID: 7597072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.
    Chun TW; Davey RT; Ostrowski M; Shawn Justement J; Engel D; Mullins JI; Fauci AS
    Nat Med; 2000 Jul; 6(7):757-61. PubMed ID: 10888923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
    Wildum S; Schindler M; Münch J; Kirchhoff F
    J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
    Miller MD; Warmerdam MT; Gaston I; Greene WC; Feinberg MB
    J Exp Med; 1994 Jan; 179(1):101-13. PubMed ID: 8270859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.